JHURX
Price
$49.88
Change
+$1.11 (+2.28%)
Updated
Jul 31 closing price
Net Assets
10.84B
RNWEX
Price
$105.35
Change
+$2.04 (+1.97%)
Updated
Jul 31 closing price
Net Assets
90.71B
Interact to see
Advertisement

JHURX vs RNWEX

JHURX vs RNWEX Comparison Chart in %
View a ticker or compare two or three
VS
JHURX vs. RNWEX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHURX is a StrongBuy and RNWEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 90.7B vs. JHURX (10.8B). RNWEX pays higher dividends than JHURX: RNWEX (0.99) vs JHURX (0.44). JHURX was incepted earlier than RNWEX: JHURX (9 years) vs RNWEX (24 years). JHURX (1.32) is less costly to investors than RNWEX (0.92). JHURX is a more actively managed with annual turnover of: 55.00 vs. RNWEX (46.00). JHURX has a lower initial minimum investment than RNWEX: JHURX (0) vs RNWEX (250). JHURX annual gain was more profitable for investors over the last year : 45.91 vs. RNWEX (21.57). JHURX return over 5 years is better than : 27.48 vs. RNWEX (17.03).
JHURXRNWEXJHURX / RNWEX
Total Expense Ratio1.240.92135%
Annual Report Gross Expense Ratio1.320.92143%
Fund Existence9 years24 years-
Gain YTD23.52613.843170%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets10.8B90.7B12%
Annual Yield % from dividends0.440.9944%
Returns for 1 year45.9121.57213%
Returns for 3 years74.4643.61171%
Returns for 5 years27.4817.03161%
Returns for 10 yearsN/A107.28-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAUX14.480.13
+0.91%
Nationwide GQG US Quality Eq A
VWNDX24.560.09
+0.37%
Vanguard Windsor Investor Shares
WDIIX17.060.01
+0.06%
Wilmington Enhanced Div Inc Strat I
PJSQX27.68-0.03
-0.11%
PGIM Jennison Small Company R6
MCRFX15.21-0.13
-0.85%
BlackRock Mid-Cap Value Investor C